Companion Animal Genetics Market Size, Share and Growth Outlook, 2026

Companion Animal Genetics Market Snapshot: Market Size, CAGR, and Growth Outlook (2021 to 2034)

The global Companion Animal Genetics Market size is forecast to increase from $916.44 Million in 2026 to $1866.66 Million in 2034 at a CAGR of 9.3% between 2026 and 2034.

The Companion Animal Genetics market report provides detailed analysis and outlook of Companion Animal Genetics segments including By Testing Service Type (Genetic Disease Testing, Genetic Trait and Performance Testing, DNA Typing and Parentage Testing), By Technology Platform (Marker-Assisted and Genomic Selection, Polymerase Chain Reaction, Next-Generation Sequencing, Gene Editing ), By Animal Type (Dogs, Cats, Horses), By Sector Type (Private Sector, Public Sector), By End-User (Breeding Companies and Associations, Veterinary Hospitals and Specialty Clinics, Research and Academic Institutes, Direct-to-Consumer) across global and regional markets. Further, analysis and outlook across 21 countries in North America, Europe, Asia Pacific, Middle East, Africa, and South America are provided in the study.

Companion Animal Genetics Industry Overview

Advancements in Canine Genomics Driving Precision Breeding and Disease Research

The companion animal genetics industry is undergoing rapid scientific advancement as large-scale genomic initiatives expand the understanding of hereditary traits, disease susceptibility, and breeding optimization in dogs. A major milestone was achieved through the DoGA Consortium, which established a comprehensive transcription-based functional map of the canine genome using 5′-end-targeted transcriptomics across more than 100 canine tissues. This extensive research generated a dataset identifying over 59,000 robust promoters and newly characterized active enhancer regions. The genomic resource provides veterinary geneticists with deeper insight into gene regulation mechanisms and supports the identification of complex disease traits, hereditary disorders, and novel therapeutic markers that can be utilized in companion animal genetic testing and precision veterinary medicine.

Emergence of Novel Genetic Biomarkers Supporting Companion Animal Screening Programs

Growing investments in canine DNA databases and genome-wide association studies are accelerating the discovery of disease-linked genetic variants. A multi-center genomic investigation successfully identified a novel genome-wide locus on chromosome 3 (CFA3) encompassing the KCNIP4 gene. Researchers established a direct association between this biomarker and the risk of idiopathic epilepsy in specific Siberian Husky populations. The discovery creates opportunities for commercial genetic screening programs that enable breeders to identify at-risk animals and reduce hereditary disease transmission within specialized breeding lines. Such developments are strengthening demand for companion animal DNA testing services and breed-specific genetic health assessments.

Integration of Machine Learning Enhancing Genetic Selection Strategies

The adoption of artificial intelligence and predictive analytics is transforming breeding decision-making across working dog programs. The Seeing Eye organization utilized genomic mapping and machine learning technologies to evaluate structural and behavioral outcomes in dogs through a long-term dataset spanning multiple decades. Researchers compared Genomic Best Linear Unbiased Prediction methodologies with machine learning algorithms to predict genetic predispositions associated with ophthalmic and structural disorders, including distichiasis and anodontia. These predictive approaches support more informed breeding selections by identifying genetic vulnerabilities before breeding candidates are chosen, improving overall population health and performance outcomes.

Expansion of Companion Animal Genetic Diagnostics

Commercial genetic diagnostics continue to expand with the introduction of targeted DNA-based screening solutions. The Canine Genetics Centre launched a dedicated DNA diagnostic test for primary hyperparathyroidism in the Keeshond breed following peer-reviewed validation studies. Researchers confirmed a strong causal relationship between the hereditary autosomal dominant disorder and a specific missense variant in the SIRT6 gene. The test utilizes buccal swab samples to accurately identify asymptomatic carriers, enabling breeders and veterinarians to implement informed breeding strategies while reducing the prevalence of severe metabolic disease within affected canine populations.

Companion Animal Genetics Market Trends, Growth Drivers, Competitive Landscape, and Future Opportunities

The global Companion Animal Genetics market is witnessing increasing investments in innovation, product development, digital transformation, artificial intelligence integration, healthcare infrastructure expansion, and strategic partnerships across developed and emerging economies. Key Companies in the industry include- Zoetis Inc. , Neogen Corporation, Mars, Incorporated , Embark Veterinary, Inc., Orivet Genetic Pet Care, Animal Genetics, Inc., Generatio GmbH, UC Davis Veterinary Genetics Laboratory, EasyDNA. The Companion Animal Genetics market is expected to remain one of the most closely watched segments in the global healthcare industry, with companies focusing on niche market segments. As healthcare systems across the US, Europe, Asia-Pacific, Latin America, and Middle East & Africa continue to prioritize efficiency, access, and innovation, the Companion Animal Genetics industry outlook remains shaped by rising healthcare expenditure, demographic change, digital transformation, and product innovation.
The report provides detailed market analysis including-

• Growth Companion Animal Genetics Market size outlook across 3 scenarios- High growth, reference, and Low growth cases

• Market Trends, Drivers, Potential Opportunities, and Challenges faced by Companion Animal Genetics companies

• Porter’s Five forces analysis- Bargaining power of buyers and sellers, Threat of Substitutes and new entrants, and Intensity of competitive rivalry

• Detailed SWOT Analysis of global and regional Companion Animal Genetics markets

• Competitive analysis including business description, product analysis, and financial profiles

• Key country specific analysis detailing key factors shaping the short-term and long-term outlook

• Recent industry developments and news including mergers, acquisitions, product launches, expansions, and company announcements

Companion Animal Genetics Market Competitive Benchmarking and Company Analysis

Leading companies in Companion Animal Genetics industry include- Zoetis Inc. , Neogen Corporation, Mars, Incorporated , Embark Veterinary, Inc., Orivet Genetic Pet Care, Animal Genetics, Inc., Generatio GmbH, UC Davis Veterinary Genetics Laboratory, EasyDNA. The Companion Animal Genetics market remains moderately to highly fragmented, with competition expected to intensify as companies accelerate investments in innovation, geographic expansion, strategic partnerships, and portfolio diversification through 2034. In developed markets such as the United States, Germany, France, the United Kingdom, and Canada, competition is increasingly centered on innovation, reimbursement positioning, and value-based healthcare solutions. Meanwhile, emerging markets including China, India, Brazil, and countries across the Middle East and Africa continue to present significant opportunities for expansion due to rising healthcare expenditure, growing patient populations, and increasing access to healthcare services.

What to expect in US Companion Animal Genetics Markets in 2026 and beyond- Market Size, Share, Growth Rate, and Forecast to 2034

The US healthcare expenditure is forecast to reach $8.2 Trillion in 2034 from $5.5 Trillion in 2026 based on the National Health Expenditure Accounts (NHEA) data. With an aging population, rising chronic disease burden, and increasing migration toward minimally invasive and outpatient care, the Companion Animal Genetics market remains one of the strongest-performing segments in the country.
The US Companion Animal Genetics Companies are opting new business models, optimized pricing models, industry partnerships, and AI-enabled back end transformations to enhance efficiency and cost management. The US Companion Animal Genetics market faces successive waves of challenging trends, with strong opportunities across select segments. The CMS plan to implement Medicaid from 2027 is driving states to build eligibility verification systems throughout 2026. Looking ahead to 2034, we anticipate stronger results underpinned by opportunities exist across Companion Animal Genetics industry. On the medical device front, over 7,000 device manufacturers continue to gain from increasing demand from demand for implantable devices, surgical instruments, monitoring equipment, and diagnostic systems.

Canada- Proximity to the US and healthcare similarities to EU5 countries fuel sales of Canadian Companion Animal Genetics markets

Canada's strong Companion Animal Genetics sales performance is underpinned by an aging population and a well-developed healthcare infrastructure. Steady growth in new brand spending in rural and urban locations fuel the long-term prospects of small and medium-sized enterprises across medical, diagnostic, and therapeutic devices. The Canadian Companion Animal Genetics market presents significant opportunities for U.S. exporters of medical devices, with the U.S. being Canada’s largest trading partner for this sector. Potential advantages including specialized materials, advanced manufacturing techniques, and digital technologies support the launch of new products in the country.

Germany Companion Animal Genetics Trends and Perspectives to 2034- Financial sustainability, hospital restructuring, demographic pressures, and digitization of care delivery continue to shape the German healthcare industry.

Germany continues to remain the largest Companion Animal Genetics market in Europe, driven by over €600 Billion healthcare expenditure, €12 Billion medical device R&D expenditure, statutory health insurance system covering 90% German population, nationwide rollout of the electronic patient record (ePA), and large-volume of Companion Animal Genetics population. In particular, Research and development in Germany fuels the commercialization of cutting-edge technologies. Companies across the Germany Companion Animal Genetics industry value chain are focusing on both domestic markets and exports. The country is also driving digital adoption with the Hospital Future Act driving hospitals to upgrade their information systems by 2027. Over the forecast period, aging population, rising healthcare costs, and increasing procedural volumes drive the Companion Animal Genetics market outlook.

France Market Size, Growth Rate, and Forecast Analysis to 2034- Universal healthcare system, high public healthcare expenditure, and strong government support Companion Animal Genetics sales through 2034

France Companion Animal Genetics companies are emphasizing on opportunities for rapid, at-scale innovation to boost profitability over the long-term. The country’s National Health Insurance spending target (ONDAM) estimates 3.7% growth in the country’s healthcare expenditure. Over the forecast period, expenditure control measures, chronic disease management initiatives, workforce reforms, and efforts to improve system efficiency drive the long-term prospects.
The biggest 2026 policy frame is the PLFSS 2026. The law sets the Maladie branch spending target at €271.4 billion for 2026 and fixes the ONDAM at €117.5 billion for city care, €112.8 billion for health establishments, and €18.3 billion for elderly-care establishments and services. France’s market is also being pulled by demographics. INSEE estimates that on 1 January 2026 France had 69.1 million inhabitants, with 22% aged 65 or over. INSEE also reported that 2025 births were 645,000 and deaths were 651,000, producing a negative natural balance of about 6,000 for the first time since the end of the Second World War.

UK Companion Animal Genetics Market Size, Share, and Growth Projections to 2034- Rapid growth driven by new and existing brands across the industry value chain

Small high-need consumer segments remain key priority of Companion Animal Genetics distributors in the UK industry. Continuous launch of new products coupled with high expenditures support the market outlook. The UK Government financing remains the dominant funding source at 81.3% of total healthcare expenditure, or £280 billion in 2025. According to the ONS, total healthcare spending grew 7.7% nominally and 3.9% in real terms from 2024 to 2025. Similarly, out-of-pocket spending was £49 billion (14.1%) and voluntary health insurance was £9.5 billion (2.8%). The market is driven by rapid digital adoption with NHS England’s plan to give more than 500,000 staff access to new AI tools.

China Companion Animal Genetics Market Growth Drivers, Revenue Trends, and Forecast- Medical insurance coverage is rapidly expanding over the past few years

China Companion Animal Genetics market is undergoing a structural shift from hospital-centric care toward a more integrated system emphasizing primary care, outpatient services, and long-term care. Chinese local players are emerging as a strong pillar of Companion Animal Genetics industry, offering opportunities for both competition and partnership. Over the forecast period, new and innovative product launches remain key elements driving market outlook. China's healthcare industry is increasingly centered on expanding healthcare capacity, improving access to advanced treatments, and reducing dependence on imported technologies.
The National Healthcare Security Administration reported that by end-2024, China’s basic medical insurance covered 1.32662 billion people and the coverage rate was 95%. Regional disparities in consumer spending trends continue to become more pronounced in the Chinese Companion Animal Genetics industry. Over the forecast period, demand will keep shifting toward geriatrics, chronic disease management, rehabilitation, long-term care, and outpatient care, while pricing pressure will remain intense in drugs and consumables because reimbursement.

India Companion Animal Genetics Market Landscape: Current Size and Long-Term Growth Outlook - Increased pricing pressures in US market is encouraging domestic vendors to expand across India

Indian Companion Animal Genetics market is witnessing the rapid emergence of an ecosystem that brings together diverse companies across the industry value chain. Further, large-scale healthcare public and private investments and a steady growth in chronic conditions is driving sales of pharmaceuticals and medical devices. Further, non-retail channel is experiencing volume decrease and patients are migrating to the retail. Indian medical device firms are also combining precision engineering with lower labor costs to make world-class diagnostics, robotics, and critical care devices.

Brazil Companion Animal Genetics market remains price-driven, with products domestically manufactured and accessibility offering potential opportunities

Healthcare expenditure in Brazil exceeds 10% of GDP, with the country among the highest healthcare spenders in Latin America. ANS reported 53.2 million medical-plan beneficiaries in December 2025, while IBGE projects a steady rise in older-age cohorts, with people aged 60+ already representing about 23% of the population. The price sensitive market access is broad through the public system, private coverage adds a sizeable premium layer, and reimbursement, procurement, and hospital efficiency remain key buying drivers.

Middle East and Africa Companion Animal Genetics Industry Trends and Perspectives to 2034

According to the World Bank, the Middle East and North Africa population exceeds 500 million, while Sub-Saharan Africa's population exceeds 1.2 billion, making the broader MEA region one of the fastest-growing healthcare demand centers globally. The GCC countries including Saudi Arabia, United Arab Emirates, Qatar, and Kuwait continue to account for a disproportionately large share of regional healthcare spending. Government-led programs such as Saudi Arabia's Vision 2030 are accelerating investments in hospital infrastructure, private-sector participation, medical technology adoption, and healthcare digitalization. On the other hand, South Africa, Egypt, Nigeria, and Kenya remain key healthcare markets due to their large populations, expanding private healthcare sectors, and growing investments in healthcare delivery systems.

Companion Animal Genetics Market Segmentation

By Testing Service Type
Genetic Disease Testing
Genetic Trait and Performance Testing
DNA Typing and Parentage Testing
By Technology Platform
Marker-Assisted and Genomic Selection
Polymerase Chain Reaction
Next-Generation Sequencing
Gene Editing
By Animal Type
Dogs
Cats
Horses
By Sector Type
Private Sector
Public Sector
By End-User
Breeding Companies and Associations
Veterinary Hospitals and Specialty Clinics
Research and Academic Institutes
Direct-to-Consumer

Top Companies in Companion Animal Genetics Industry

Zoetis Inc.
Neogen Corporation
Mars, Incorporated
Embark Veterinary, Inc.
Orivet Genetic Pet Care
Animal Genetics, Inc.
Generatio GmbH
UC Davis Veterinary Genetics Laboratory
EasyDNA

Countries Included

• North America- US, Canada, Mexico

• Europe- Germany, France, UK, Spain, Italy, Nordics, Others

• Asia Pacific- China, India, Japan, South Korea, Australia, Southeast Asia, Others

• Latin America- Brazil, Argentina, Others

• Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa

Latest Market Updates In Healthcare

Support this report with fresh, same-industry updates that strengthen topical depth and internal linking.

Market Update

Rise of Functional and Clinical-Grade Skincare

The rising geopolitical and tariff-related uncertainties, in particular, amidst United States’ renewed protectionist trade stance continues to driv...

June 2025

Market Update

Biotech and Fermented Ingredient Integration to gain rapid penetration

The rising geopolitical and tariff-related uncertainties, in particular, amidst United States’ renewed protectionist trade stance continues to driv...

June 2025

Market Update

Low MOQ, High-Mix Production Models for Indie & DTC Brands

The rising geopolitical and tariff-related uncertainties, in particular, amidst United States’ renewed protectionist trade stance continues to driv...

June 2025